Answers are grounded in this paper and cite their sources.
BACKGROUND: Anorexia nervosa (AN) is a severe psychiatric disorder with high mortality, yet its biological underpinnings remain unclear. Gut-brain peptides, which influence brain function through circulatory and vagal routes, have emerged as potential contributors to AN, though causal relationships remain unexplored. Given the unclear biological mechanisms and lack of biomarkers for AN, this study aims to explore the causal role of gut-brain peptides in AN development, in order to identify potential diagnostic or therapeutic targets. METHODS: We applied Mendelian randomization (MR) to assess the causal effects of 12 gut-brain peptides on AN risk, using genome-wide association study (GWAS) data from populations of European ancestry. The inverse variance weighted (IVW) method was the primary analytic tool, supplemented with sensitivity analyses. Peptides showing associations with AN were also tested across five other psychiatric disorders: schizophrenia (SCZ), major depressive disorder (MDD), bipolar disorder (BD), autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD)-were also explored. No significant associations were found for the other peptides. Reverse MR showed that genetic liability to AN was associated with reduced levels of leptin and chromogranin A (CgA). These associations were not observed in the five other psychiatric disorders. CONCLUSIONS: This study identifies PYY as a potential causal factor in AN and highlights leptin and CgA as downstream biomarkers. These findings suggest gut-brain peptides may be uniquely involved in AN pathogenesis, offering targets for early detection and therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: